Building a Safer CAR-T Therapy
Ludwig Cancer Research | February4th,2020
A new study addresses a central conundrum of CAR-T therapies: their tendency to provoke potentially deadly runaway immune responses against healthy tissues in patients
CAR-T
Car-T Therapy Improves Outcomes for Patients with B-Cell Lymphoma
University of Chicago Medical Center | December3rd,2018
Forty percent of patients with diffuse large B-cell lymphoma had a complete response, most of which were durable